Philipe Gobeil

866 total citations · 1 hit paper
9 papers, 496 citations indexed

About

Philipe Gobeil is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Biotechnology. According to data from OpenAlex, Philipe Gobeil has authored 9 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Biotechnology. Recurrent topics in Philipe Gobeil's work include SARS-CoV-2 and COVID-19 Research (3 papers), Transgenic Plants and Applications (3 papers) and Veterinary Oncology Research (3 papers). Philipe Gobeil is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Transgenic Plants and Applications (3 papers) and Veterinary Oncology Research (3 papers). Philipe Gobeil collaborates with scholars based in United Kingdom, Canada and United States. Philipe Gobeil's co-authors include David A. Leib, Noreen Rapin, Vikram Misra, M. Saveria Campo, Peter O’Hare, Zhengqiang Yuan, Camilo Raggo, Nathalie Landry, Brian J. Ward and Iohann Boulay and has published in prestigious journals such as Nature Medicine, Nature Communications and Molecular and Cellular Biology.

In The Last Decade

Philipe Gobeil

9 papers receiving 492 citations

Hit Papers

Phase 1 randomized trial of a plant-derived virus-like pa... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philipe Gobeil United Kingdom 7 196 133 124 121 105 9 496
Robert G. Tuskan United States 15 241 1.2× 82 0.6× 100 0.8× 276 2.3× 31 0.3× 19 703
Mizuho Kajikawa Japan 17 412 2.1× 82 0.6× 260 2.1× 444 3.7× 57 0.5× 40 986
Lukai Zhai United States 10 159 0.8× 72 0.5× 181 1.5× 89 0.7× 11 0.1× 14 418
Andrea S. Rópolo Argentina 15 200 1.0× 132 1.0× 105 0.8× 216 1.8× 11 0.1× 32 689
Katja Klein United Kingdom 16 203 1.0× 127 1.0× 111 0.9× 265 2.2× 85 0.8× 27 596
T. Scott Manetz United States 11 287 1.5× 89 0.7× 40 0.3× 481 4.0× 18 0.2× 15 823
Teodora Kaltcheva United States 13 145 0.7× 152 1.1× 209 1.7× 191 1.6× 167 1.6× 21 688
Jason A. Iskarpatyoti United States 8 370 1.9× 203 1.5× 122 1.0× 478 4.0× 7 0.1× 10 784
Longbo Hu China 13 166 0.8× 115 0.9× 118 1.0× 256 2.1× 4 0.0× 27 591
Karen M. Scanlon United States 14 165 0.8× 106 0.8× 139 1.1× 101 0.8× 16 0.2× 24 462

Countries citing papers authored by Philipe Gobeil

Since Specialization
Citations

This map shows the geographic impact of Philipe Gobeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipe Gobeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipe Gobeil more than expected).

Fields of papers citing papers by Philipe Gobeil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipe Gobeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipe Gobeil. The network helps show where Philipe Gobeil may publish in the future.

Co-authorship network of co-authors of Philipe Gobeil

This figure shows the co-authorship network connecting the top 25 collaborators of Philipe Gobeil. A scholar is included among the top collaborators of Philipe Gobeil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipe Gobeil. Philipe Gobeil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kapłonek, Paulina, Deniz Cizmeci, Sally Shin, et al.. (2023). Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19. npj Vaccines. 8(1). 13–13. 4 indexed citations
2.
Gobeil, Philipe, Stéphane Pillet, Iohann Boulay, et al.. (2022). Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19. Nature Communications. 13(1). 6905–6905. 7 indexed citations
3.
Ward, Brian J., Philipe Gobeil, Annie Séguin, et al.. (2021). Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nature Medicine. 27(6). 1071–1078. 214 indexed citations breakdown →
4.
Gobeil, Philipe & David A. Leib. (2012). Herpes Simplex Virus γ34.5 Interferes with Autophagosome Maturation and Antigen Presentation in Dendritic Cells. mBio. 3(5). e00267–12. 74 indexed citations
5.
Gobeil, Philipe, Zhengqiang Yuan, E. A. Gault, et al.. (2009). Small interfering RNA targeting bovine papillomavirus type 1 E2 induces apoptosis in equine sarcoid transformed fibroblasts. Virus Research. 145(1). 162–165. 11 indexed citations
6.
Yuan, Zhengqiang, Philipe Gobeil, M. Saveria Campo, & Lubna Nasir. (2009). Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive. Virology. 396(1). 143–151. 30 indexed citations
7.
Yuan, Zhengqiang, E. A. Gault, Philipe Gobeil, et al.. (2008). Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: Model systems for equine sarcoids. Virology. 373(2). 352–361. 39 indexed citations
8.
Gobeil, Philipe, E. A. Gault, M. Saveria Campo, et al.. (2007). Equine sarcoids are not induced by an infectious cell line. Equine Veterinary Journal. 39(2). 189–191. 3 indexed citations
9.
Raggo, Camilo, et al.. (2002). Luman, the Cellular Counterpart of Herpes Simplex Virus VP16, Is Processed by Regulated Intramembrane Proteolysis. Molecular and Cellular Biology. 22(16). 5639–5649. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026